Tempest Therapeutics (TPST)

• Market cap: $14.3M
• 1 day: 0.69%
• 5 days: -5.48%
• 1 month: -68.76%
• 3 months: -69.42%
• 6 months: -57.23%
• Year to date: -73.75%
• 1 year: -71.47%
• 5 years: -99.3%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Employees: 5